Related Experiment Video
Updated: Aug 11, 2026
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Ethical considerations in psychopharmacological research involving children and adolescents
1Child and Adolescent Treatment and Preventive Intervention Research Branch, NIMH, MSC 9633, Bethesda, MD 20892-9633, USA. bvitiell@mail.nih.gov
Insights
Pediatric psychopharmacology research requires children
Area of Science:
- Pediatric Psychopharmacology
- Bioethics
- Clinical Research
Background:
- Rising use of psychotropic medications in children necessitates research into pediatric psychopharmacology.
- Ethical considerations are paramount in pediatric psychopharmacology research involving child participants.
Purpose of the Study:
- To examine the ethical dimensions of including children in psychopharmacology research protocols.
- To highlight the need for specialized regulations governing pediatric research.
Main Methods:
- A selective review of pertinent scientific and regulatory literature was conducted.
- Analysis focused on ethical guidelines and challenges in pediatric psychopharmacology research.
Main Results:
- Child participation in research is essential as adult data is insufficient for efficacy and safety.
- Special regulations apply to child research, with risk/benefit ratios critical for direct benefit studies.
- Minimal risk and minor increase over minimal risk concepts vary in application; empirical data is lacking.
Conclusions:
- Further research into human subject issues is crucial for advancing ethical pediatric psychopharmacology.
- Improving ethical methods and procedures in pediatric psychopharmacology research is a key outcome.
Rationale:
Increased community utilization of psychotropic medications among children has brought attention to pediatric psychopharmacology research and associated ethical issues.
Objectives:
To discuss ethical aspects of child participation in psychopharmacology protocols.
Methods:
Selective review of relevant scientific and regulatory literature.
Results:
Efficacy and safety of psychotropics in children cannot be entirely inferred from adult data and direct participation of children in research is necessary. Child research must follow special regulations that are in addition to those common to all human research. For research with prospect of direct benefit, a critical factor is whether the risk/benefit ratio is favorable to the participating child. For research without such a prospect, the concepts of minimal risk and minor increase over minimal risk apply. However, the interpretation and application of these principles to specific protocols vary across settings and among ethics committees. Thus far, little empirical investigation has been conducted on children and parents' motivation for research participation, effectiveness of the informed consent and assent procedures, possibility of persistent consequences of exposure to experimental treatments and placebo, and validation of the concepts of minimal risk and minor increase over minimal risk.
Conclusions:
Research on human subject issues relevant to child participation is a promising approach to improving ethical methods and procedures of pediatric psychopharmacology.
Related Concept Videos
01:56Ethics in Research
01:21Factors Affecting Drug Response: Overview
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:30Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...